Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health’s Monoject Syringes
Friday, the FDA said that Becton, Dicki
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Roundup weedkiller, prompted by multi-billion dollar verdicts
IBM Goes Big On Quantum Computing Game, Extends Development Roadmap To 2033
International Business Machines Corp (NYSE: IBM) launches 'IBM Quantum Heron,' the first in a new series
Dow’s New All-Time-High: DIA Outperforms SPY In November — This Component Stock Is Up Over 90% YTD
The Dow Jones Industrial Average Index hit a new ATH of 36,264.85. DIA ETF overtakes SPY ETF over the past 5 days and the month.
Al Jaber Controversy At COP28: Event’s President Says ‘No Science’ Comments Misrepresented
Global oil prices fell on Monday after COP28 president Sultan Al Jaber hit back at criticisms of comments he made before the climate summit.
Exxon Defends Carbon Capture Amid Skepticism At COP28: Report
On Saturday, the oil giant Exxon Mobil Corp's (NYSE: XOM) CEO Darren Woods reportedly rejected the International Energy Agency's (IEA) recent claim that using wide-scale carbon capture to fight climate change was an implausible "illusion" at the
McDonald’s Decision To Bet On China Seems Risky But May Pay-Off Greatly: Report
McDonald's Corp's (NYSE: MCD) decision to take greater control of its China business and expand aggressively amid consumer slowdown and geopolitical tensions reportedly seems risky, but the potential pay-off is great.
Stocks Set To For A Weak Open, Gold Hits Record Highs, Bitcoin Soars Past $40,000
As the first week of December kicked off, U.S. stock futures are set to open on a weaker note after enjoying substantial gains both the prior Friday and throughout November.
AMD Exec Forrest Norrod Expects AI Revenue To Exceed $2B In 2024 Thanks To MI300
On the AI front, Norrod expects extraordinary interest levels over the next 24 months, with AMD's MI300 revenue exceeding $2 billion in 2024.
Top Contenders Emerge in Johnson & Johnson’s Race for New CEO, Plans Under Spotlight After Unexpected Departure
The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit, potentially altering the anticipated succession plans within the healthcare giant